RSS-Feed abonnieren

DOI: 10.1055/s-0045-1813673
Vascular and Nonvascular Interventions in Gynecology
Autor*innen
Abstract
Advancements in radiology have revolutionized medicine, making image-guided procedures the standard of care due to their precision and minimally invasive nature. In gynecology, these interventions are classified into nonvascular and vascular procedures. Nonvascular interventions include diagnostic biopsies and therapeutic procedures such as high-intensity focused ultrasound, radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation (CA), and sclerotherapy. Vascular interventions are primarily therapeutic, including uterine artery embolization (UAE), gonadal vein embolization (GVE), and iliac/renal vein stenting.
Nonvascular interventions can be performed via transabdominal, transvaginal, or transrectal routes under ultrasound guidance, or transabdominal or transgluteal routes under computed tomography guidance. Biopsies are used to evaluate complex adnexal masses, while aspiration and drainage procedures manage ovarian cysts and pelvic collections. Sclerotherapy is an alternative to laparoscopic cystectomy for ovarian endometriomas, and RFA, MWA, and CA are used for uterine fibroids and hepatic metastasis in ovarian malignancies.
Vascular interventions, such as UAE, are effective for treating uterine fibroids and adenomyosis, offering a minimally invasive alternative to surgery. UAE reduces fibroid size and alleviates symptoms, with a high success rate. UAE is moderately effective in providing symptomatic relief in adenomyosis for patients who desire to preserve the uterus. Embolization is also used for managing bleeding in gynecological malignancies and treating pelvic venous disease (PeVD). GVE and pelvic varicosities sclerotherapy are effective for PeVD, while venous stenting addresses vein compression.
Image-guided interventions provide safe and effective diagnostic and therapeutic options for various gynecological conditions, improving patient outcomes and preserving fertility.
Publikationsverlauf
Artikel online veröffentlicht:
03. Dezember 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Griffin N, Grant LA, Freeman SJ. et al. Image-guided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique?. Eur Radiol 2009; 19 (01) 230-235
- 2 Thabet A, Somarouthu B, Oliva E, Gervais DA, Hahn PF, Lee SI. Image-guided ovarian mass biopsy: efficacy and safety. J Vasc Interv Radiol 2014; 25 (12) 1922-1927.e1
- 3 Andreotti RF, Timmerman D, Strachowski LM. et al. O-RADS US risk stratification and management system: a consensus guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. Radiology 2020; 294 (01) 168-185
- 4 Royal College of Obstetricians and Gynaecologists. The management of ovarian cysts in postmenopausal women. Green-top Guideline No. 34. London, England: Royal College of Obstetricians and Gynaecologists; 2011. . Accessed February 13, 2025, at: https://www.rcog.org.uk/media/4v3ncfib/gtg_34.pdf
- 5 Singh S, Chaudhary P, Saxena N, Khandelwal S, Poddar DD, Biswal UC. Treatment of liver abscess: prospective randomized comparison of catheter drainage and needle aspiration. Ann Gastroenterol 2013; 26 (04) 332-339
- 6 Cohen A, Almog B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril 2017; 108 (01) 117-124.e5
- 7 Han K, Seo SK, Kim MD. et al. Catheter-directed sclerotherapy for ovarian endometrioma: short-term outcomes. Radiology 2018; 289 (03) 854-859
- 8 Chen I, Berman JM, Balk EM. et al. Radiofrequency ablation for the treatment of uterine fibroids: a systematic review and meta-analysis by the AAGL Practice Committee. J Minim Invasive Gynecol 2025; 32 (01) 74-91
- 9 Rey VE, Labrador R, Falcon M, Garcia-Benitez JL. Transvaginal radiofrequency ablation of myomas: technique, outcomes, and complications. J Laparoendosc Adv Surg Tech A 2019; 29 (01) 24-28
- 10 Yin G, Chen M, Yang S, Li J, Zhu T, Zhao X. Treatment of uterine myomas by radiofrequency thermal ablation: a 10-year retrospective cohort study. Reprod Sci 2015; 22 (05) 609-614
- 11 Gervais DA, Arellano RS, Mueller PR. Percutaneous radiofrequency ablation of ovarian cancer metastasis to the liver: indications, outcomes, and role in patient management. AJR Am J Roentgenol 2006; 187 (03) 746-750
- 12 Ierardi AM, Savasi V, Angileri SA. et al. Percutaneous high frequency microwave ablation of uterine fibroids: systematic review. BioMed Res Int 2018; 2018: 2360107 , 1-9
- 13 Liu H, Zhang J, Han ZY. et al. Effectiveness of ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroids: a multicentre study in China. Int J Hyperthermia 2016; 32 (08) 876-880
- 14 Poulou LS, Botsa E, Thanou I, Ziakas PD, Thanos L. Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Hepatol 2015; 7 (08) 1054-1063
- 15 Silberzweig JE, Powell DK, Matsumoto AH, Spies JB. Management of uterine fibroids: a focus on uterine-sparing interventional techniques. Radiology 2016; 280 (03) 675-692
- 16 De Maio A, Alfieri G, Mattone M, Ghanouni P, Napoli A. High-intensity focused ultrasound surgery for tumor ablation: a review of current applications. Radiol Imaging Cancer 2024; 6 (01) e230074
- 17 Bertolotti L, Bazzocchi MV, Iemma E. et al. Radiofrequency ablation, cryoablation, and microwave ablation for the treatment of small renal masses: efficacy and complications. Diagnostics (Basel) 2023; 13 (03) 388
- 18 Li HW, Long YJ, Yan GW. et al. Microwave ablation vs. cryoablation for treatment of primary and metastatic pulmonary malignant tumors. Mol Clin Oncol 2022; 16 (03) 62
- 19 Zhao Z, Guo Z, Ni H, Liu F, Li B. CT-monitored percutaneous cryoablation of uterine fibroids after uterine artery embolization. Chin J Clin Oncol 2007; 4 (04) 241-245
- 20 Gao W, Guo Z, Zhang X. et al. Percutaneous cryoablation of ovarian cancer metastasis to the liver. Int J Gynecol Cancer 2015; 25 (05) 802-808
- 21 Tanaka ME, Keefe N, Caridi T, Kohi M, Salazar G. Interventional radiology in obstetrics and gynecology: updates in women's health. Radiographics 2023; 43 (03) e220039
- 22 Rezaei-Kalantari K, Fahrni G, Rotzinger DC, Qanadli SD. Insights into pelvic venous disorders. Front Cardiovasc Med 2023; 10: 1102063
- 23 Stewart JK. Uterine artery embolization for uterine fibroids: a closer look at misperceptions and challenges. Tech Vasc Interv Radiol 2021; 24 (01) 100725
- 24 Bradley EA, Reidy JF, Forman RG, Jarosz J, Braude PR. Transcatheter uterine artery embolisation to treat large uterine fibroids. Br J Obstet Gynaecol 1998; 105 (02) 235-240
- 25 Ozen M, Patel R, Hoffman M, Raissi D. Update on endovascular therapy for fibroids and adenomyosis. Semin Intervent Radiol 2023; 40 (04) 327-334
- 26 Chan P, Garcia-Reyes K, Cronan J. et al. Managing postembolization syndrome-related pain after uterine fibroid embolization. Semin Intervent Radiol 2021; 38 (03) 382-387
- 27 Peng J, Wang J, Shu Q, Luo Y, Wang S, Liu Z. Systematic review and meta-analysis of current evidence in uterine artery embolization vs myomectomy for symptomatic uterine fibroids. Sci Rep 2024; 14 (01) 19252
- 28 Mailli L, Patel S, Das R. et al. Uterine artery embolisation: fertility, adenomyosis and size - what is the evidence?. CVIR Endovasc 2023; 6 (01) 8
- 29 Kröncke T. An update on uterine artery embolization for uterine leiomyomata and adenomyosis of the uterus. Br J Radiol 2023; 96 (1143): 20220121
- 30 Manyonda I, Belli AM, Lumsden MA. et al; FEMME Collaborative Group. Uterine-artery embolization or myomectomy for uterine fibroids. N Engl J Med 2020; 383 (05) 440-451
- 31 de Bruijn AM, Ankum WM, Reekers JA. et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. Am J Obstet Gynecol 2016; 215 (06) 745.e1-745.e12
- 32 Caridi TM. Uterine artery embolization for adenomyosis. Tech Vasc Interv Radiol 2021; 24 (01) 100726
- 33 Alméciga A, Rodriguez J, Beltrán J. et al. Emergency embolization of pelvic vessels in patients with locally advanced cervical cancer and massive vaginal bleeding: a case series in a Latin American Oncological Center. JCO Glob Oncol 2020; 6 (06) 1376-1383
- 34 Choi J, Shin JH, Chu HH. Transcatheter arterial embolization for palliation of uterine body cancer bleeding. J Korean Soc Radiol 2023; 84 (03) 606-614
- 35 Khilnani NM, Winokur RS, Scherer KL, Meissner MH. Clinical presentation and evaluation of pelvic venous disorders in women. Tech Vasc Interv Radiol 2021; 24 (01) 100730
- 36 Topper SR, Winokur RS. Imaging of pelvic venous disorders (PeVD); should every patient get an MRI?. Tech Vasc Interv Radiol 2021; 24 (01) 100731
- 37 Joh M, Grewal S, Gupta R. Ovarian vein embolization: how and when should it be done?. Tech Vasc Interv Radiol 2021; 24 (01) 100732
- 38 Kutsenko O, McColgan Y, Salazar G. Iliac vein stenosis: is the data strong enough for stenting in the young pelvic venous disorders (PeVD) population?. Tech Vasc Interv Radiol 2021; 24 (01) 100733

